Bova UK is hosting a module on the Foundations and Pathogenesis of FIP from 19 October to 6 November 2026.

Register for new product notifications on the homepage of the website. Bova UK is a Specials Manufacturer dedicated to the veterinary market and is regulated by the Veterinary Medicines Directorate (VMD). It is the first in the UK to hold a ManSA (Manufacturer ‘Specials’ Authorisation) to manufacture sterile and non-sterile products for the veterinary market. Nicholas Bova founded the company in 2008, which specialised in this niche market in Australia - the largest of its kind nationally- and brings over ten years of its experience to the UK veterinary market. Currently servicing the equine, small animal (dog and cat), and exotic markets, with plans for numerous formulation releases in 2019, 2020 and beyond. Products attributes: Urgent market shortages Oral Pastes Oral Suspensions Transdermal Creams Thermo-Reversible Gel Synthetic Flavouring (no animal protein) pH Friendly Formulations Sterile Injectable Ophthalmic Preparations Chemotherapy & Cytotoxic Agents Tablets (soon to be released) Capsules Products no longer on the market The Synthetic Flavourings used at Bova UK does not contain animal protein and will increase in choice as the business grows. The flavours available, which are widely popular, include: Molasses Chicken Grilled Chicken Roast Chicken Beef Liver,beef, bacon The well-established quality culture ensures that the business remains compliant with current Good Manufacturing Practices (cGMP) and Good laboratory practices (GLP). Bova UK laboratories are fitted with specialty high-tech equipment in its world-class, brand new facility. All raw materials and finished products are tested against set standards as per ICH guidelines and the facility is due to open its newly built analytical laboratories to perform stability studies on new & existing products to monitor and improve product quality and patient safety.